Jane Wasman

2010

In 2010, Jane Wasman earned a total compensation of $2.1M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 50% increase compared to previous year.

Compensation breakdown

Bonus$180,503
Option Awards$811,848
Salary$366,783
Stock Awards$684,000
Other$7,350
Total$2,050,484

Wasman received $811.8K in option awards, accounting for 40% of the total pay in 2010.

Wasman also received $180.5K in bonus, $366.8K in salary, $684K in stock awards and $7.4K in other compensation.

Rankings

In 2010, Jane Wasman's compensation ranked 2,987th out of 10,439 executives tracked by ExecPay. In other words, Wasman earned more than 71.4% of executives.

ClassificationRankingPercentile
All
2,987
out of 10,439
71st
Division
Manufacturing
1,039
out of 3,838
73rd
Major group
Chemicals And Allied Products
201
out of 921
78th
Industry group
Drugs
105
out of 680
85th
Industry
Biological Products, Except Diagnostic Substances
18
out of 142
87th
Source: SEC filing on April 19, 2013.

Wasman's colleagues

We found four more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2010.

2010

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2010

Andrew Blight

Acorda Therapeutics

Chief Scientific Officer

2010

David Lawrence

Acorda Therapeutics

Chief Financial Officer

2010

Thomas Wessel

Acorda Therapeutics

Chief Medical Officer

News

You may also like